MedPath
NMPA Approval

Osimertinib Mesylate Tablets

国药准字H20234357

October 24, 2023

Drug Information

甲磺酸奥希替尼片

片剂

80mg(按C₂₈H₃₃N₇O₂计)

化学药品

October 24, 2023

Company Information

Applicant Company

江苏省徐州市金山桥开发区综合区洞山南侧

Manufacturing Company

江苏省徐州市金山桥开发区综合区洞山南侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸奥希替尼片 - NMPA 批准文号 | MedPath